News & Analysis on Clinical Trial Services & Contract Research And Development
Invitrogen and Signalomics have agreed terms to develop nanotechnology-based laboratory approaches to cancer diagnostics in a move that is set to make the identification of tumours easier and quicker.
As the threat of new viruses like avian influenza have heightened the need for greater speed and safety in vaccine production, single use technologies are proving far more safe and economic than traditional cleaning techniques, according to Pall's...
Agilent Technologies has stepped out of its comfort zone to pursue a new line of business in ribonucleic acid (RNA) production, with the recent acquisition of SynPro.
Kurve Technology has announced it has entered into a partnership with US pharmaceutical firm Schering-Plough involving its nasal drug delivery device which promises greater efficacy and efficiency than traditional devices such as spray pumps.